Clinical Cancer Drugs

Editor-in-Chief

Giulio Francia
The University of Texas
El Paso, TX
(USA)

Personal Subscription
Become EABM
Become Reviewer

Articles Ahead of Print

A Phase I Study of OMN54 (Aneustat™) in Patients with Advanced Malignancies

Volume:7
Karen A Gelmon*, Christian Kollmannsberger, Stephen Chia, Anna V. Tinker, Teresa Mitchell, Stephen Lam, Teresa Joshi, David Kwok, John Ostrem, Simon Sutcliffe and Daniel J Renouf

Alsevirone-NF Reduces Serum Testosterone and Inhibits Prostate Cancer Xenograft Growth in Balb/c Nude Mice

Volume:7
Pokrovsky V.S.*, Zolottsev V.A., Latysheva A.S., Kudinov V.A., Anisimova N.Yu., Almanza R.L.M., Alekseeva O.Yu., Baskaev K.K., Smirnova G.B., Borisova Yu.A. and Ipatova O.M.

A Maximum Entropy Estimator for the Average Survival Time Differences between Two Groups

Volume:7
Marian Manciu*, Sorour Hosseini and Joscelyne Guzman-Gonzalez

Withdrawn: Intraoperative Sono-photodynamic Therapy for Anaplastic Astrocytoma Grade III With Transformation in Glioblastoma Grade IV

Volume:4
Dmitry Tzerkovsky*, Fedor Borichevsky, Yuri Grachev and Yuri Istomin